Hassan Ghoz1, Alex Kesler2, Sanne A Hoogenboom1, Filippo Gavi3, Bhaumik Brahmbhatt1, John Cangemi1, Paul T Kröner4. 1. Department of Gastroenterology and Hepatology, Mayo Clinic Florida, 4500 San Pablo Rd S, Jacksonville, FL, 32224, USA. 2. Department of Medicine, Mayo Clinic Florida, Jacksonville, Florida, USA. 3. Department of Medicine, Universidad Europea de Madrid, Madrid, Spain. 4. Department of Gastroenterology and Hepatology, Mayo Clinic Florida, 4500 San Pablo Rd S, Jacksonville, FL, 32224, USA. Kroner.Paul@mayo.edu.
Abstract
BACKGROUND: Ulcerative colitis (UC) is primarily medically managed. Colectomy is required in patients with refractory disease or severe complications. Older studies have reported 20-year colectomy rates of over 50%, but recent studies showed decreased rates to 15%. Temporal trends in the use of colectomy in UC over the past decade (when the use of biologics has become widespread) are lacking. METHODS: Case-control study using the National Inpatient Sample database for years of 2007, 2010, 2013, and 2016 was performed. The primary outcome was determining the temporal trends in the use of colectomy in hospitalized patients with UC. Secondary outcomes were determining the total number of admissions for patients with UC and associated trend in inflation-adjusted hospital costs, charge, and length of hospital stay (LOS). Multivariate regression analyses were used to adjust for other co-variables. RESULTS: 443,043 patients with UC were identified, of which 19,208 underwent colectomy in the study period. The mean patient age was 52 years, and 47% were female. Five percent of hospitalized patients with UC underwent colectomy in 2007, while 2.7% of patients with UC had colectomy in 2016, representing a 46% decrease in colectomies in hospitalized patients in the study period. Patients with UC displayed adjusted odds of colectomy of 0.51 (p < 0.01), adjusted additional mean hospital costs decrease by - $2898 (p < 0.01), hospital charges increase by $26,554 (p < 0.01), LOS decrease by - 2.2 days (p < 0.01) in 2016 compared to 2007. CONCLUSION: The odds of colectomy in UC patients decreased significantly over the past decade, likely secondary to improved medical care.
BACKGROUND:Ulcerative colitis (UC) is primarily medically managed. Colectomy is required in patients with refractory disease or severe complications. Older studies have reported 20-year colectomy rates of over 50%, but recent studies showed decreased rates to 15%. Temporal trends in the use of colectomy in UC over the past decade (when the use of biologics has become widespread) are lacking. METHODS: Case-control study using the National Inpatient Sample database for years of 2007, 2010, 2013, and 2016 was performed. The primary outcome was determining the temporal trends in the use of colectomy in hospitalized patients with UC. Secondary outcomes were determining the total number of admissions for patients with UC and associated trend in inflation-adjusted hospital costs, charge, and length of hospital stay (LOS). Multivariate regression analyses were used to adjust for other co-variables. RESULTS: 443,043 patients with UC were identified, of which 19,208 underwent colectomy in the study period. The mean patient age was 52 years, and 47% were female. Five percent of hospitalized patients with UC underwent colectomy in 2007, while 2.7% of patients with UC had colectomy in 2016, representing a 46% decrease in colectomies in hospitalized patients in the study period. Patients with UC displayed adjusted odds of colectomy of 0.51 (p < 0.01), adjusted additional mean hospital costs decrease by - $2898 (p < 0.01), hospital charges increase by $26,554 (p < 0.01), LOS decrease by - 2.2 days (p < 0.01) in 2016 compared to 2007. CONCLUSION: The odds of colectomy in UCpatients decreased significantly over the past decade, likely secondary to improved medical care.
Authors: Conor G Loftus; Edward V Loftus; W Scott Harmsen; Alan R Zinsmeister; William J Tremaine; L Joseph Melton; William J Sandborn Journal: Inflamm Bowel Dis Date: 2007-03 Impact factor: 5.325
Authors: Johan Askling; C Michael Fored; Lena Brandt; Eva Baecklund; Lennart Bertilsson; Nils Feltelius; Lars Cöster; Pierre Geborek; Lennart T Jacobsson; Staffan Lindblad; Jörgen Lysholm; Solbritt Rantapää-Dahlqvist; Tore Saxne; Ronald F van Vollenhoven; Lars Klareskog Journal: Ann Rheum Dis Date: 2007-01-29 Impact factor: 19.103
Authors: Kymberley Thorne; Laith Alrubaiy; Ashley Akbari; David G Samuel; Sian Morrison-Rees; Stephen E Roberts Journal: Eur J Gastroenterol Hepatol Date: 2016-04 Impact factor: 2.566
Authors: Tom Øresland; Willem A Bemelman; Gianluca M Sampietro; Antonino Spinelli; Alastair Windsor; Marc Ferrante; Philippe Marteau; Oded Zmora; Paulo Gustavo Kotze; Eloy Espin-Basany; Emmanuel Tiret; Giuseppe Sica; Yves Panis; Arne E Faerden; Livia Biancone; Imerio Angriman; Zuzana Serclova; Anthony de Buck van Overstraeten; Paolo Gionchetti; Laurents Stassen; Janindra Warusavitarne; Michel Adamina; Axel Dignass; Rami Eliakim; Fernando Magro; André D'Hoore Journal: J Crohns Colitis Date: 2015-01 Impact factor: 10.020